Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Q47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,998
Award facts
- Contract value 100% obligated
- $15,998.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,998.32 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 19, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. Dupixent (dupilumab) is a specialty biologic treatment indicated for conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis, reflecting AmerisourceBergen's role in delivering high-value specialty pharmaceutical products to support Defense Health Agency medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F1Q47?
SPE2DR26F1Q47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F1Q47 worth?
The government has obligated $15,998 on SPE2DR26F1Q47.
Is contract SPE2DR26F1Q47 an order under another contract?
Yes. SPE2DR26F1Q47 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Q47 competed?
The extent of competition for SPE2DR26F1Q47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award